Subregional analysis of GABAA receptor subunit mRNAs in the hippocampus of older persons with and without cognitive impairment

RA Rissman, DA Bennett, DM Armstrong - Journal of chemical …, 2004 - Elsevier
We employed in situ hybridization and quantitative densitometry techniques to examine
hippocampal mRNA expression of GABAA receptor subunits α1 and α5 in human subjects …

[HTML][HTML] GABAergic dysfunction, neural network hyperactivity and memory impairments in human aging and Alzheimer's disease

J Jiménez-Balado, TS Eich - Seminars in cell & developmental biology, 2021 - Elsevier
In this review, we focus on the potential role of the γ-aminobutyric acidergic (GABAergic)
system in age-related episodic memory impairments in humans, with a particular focus on …

GABAA receptor β2 and β3 subunits mRNA in the hippocampal formation of aged human brain with Alzheimer-related neuropathology

K Mizukami, DR Grayson, MD Ikonomovic… - Molecular brain …, 1998 - Elsevier
Our work on the role of glutamate in Alzheimer's disease (AD)-related neuronal vulnerability
and death provided significant insight into the potential contribution of the γ-aminobutyric …

GABAergic microcircuits in Alzheimer's disease models

V Villette, P Dutar - Current Alzheimer Research, 2017 - ingentaconnect.com
Background: The early phase of Alzheimer's disease (AD) involves the disruption of finely
tuned neuronal circuitry in brain regions associated with learning and memory. This tuning is …

Downregulation of GABA transporter 3 (GAT3) is associated with deficient oxidative GABA metabolism in human induced pluripotent stem cell-derived astrocytes in …

C Salcedo, A Wagner, JV Andersen, KT Vinten… - Neurochemical …, 2021 - Springer
Alterations in neurotransmitter homeostasis, primarily of glutamate and GABA, is strongly
implicated in the pathophysiology of Alzheimer's disease (AD). Homeostasis at the synapse …

Biochemical analysis of GABAA receptor subunits α1, α5, β1, β2 in the hippocampus of patients with Alzheimer's disease neuropathology

RA Rissman, AJ Mishizen-Eberz, TL Carter, BB Wolfe… - Neuroscience, 2003 - Elsevier
Alzheimer's disease (AD) is characterized by selective vulnerability of specific neuronal
populations within particular brain regions. For example, hippocampal glutamatergic cell …

Changes in hippocampal GABABR1 subunit expression in Alzheimer's patients: association with Braak staging

M Iwakiri, K Mizukami, MD Ikonomovic, M Ishikawa… - Acta …, 2005 - Springer
Alterations in the γ-aminobutyric acid (GABA) neurotransmitter and receptor systems may
contribute to vulnerability of hippocampal pyramidal neurons in Alzheimer's disease (AD) …

Implications of GABAergic neurotransmission in Alzheimer's disease

Y Li, H Sun, Z Chen, H Xu, G Bu… - Frontiers in aging …, 2016 - frontiersin.org
Alzheimer's disease (AD) is characterized pathologically by the deposition of β-amyloid
peptides (Aβ) and the accumulation of neurofibrillary tangles (NFTs) composed of hyper …

Glia: a major player in glutamate–GABA dysregulation‐mediated neurodegeneration

A Sood, K Preeti, V Fernandes… - Journal of …, 2021 - Wiley Online Library
The imbalance between glutamate and γ‐aminobutyric acid (GABA) results in the loss of
synaptic strength leading to neurodegeneration. The dogma on the field considered neurons …

Density of GABAB Receptors Is Reduced in Granule Cells of the Hippocampus in a Mouse Model of Alzheimer's Disease

A Martín-Belmonte, C Aguado, R Alfaro-Ruíz… - International journal of …, 2020 - mdpi.com
Metabotropic γ-aminobutyric acid (GABAB) receptors contribute to the control of network
activity and information processing in hippocampal circuits by regulating neuronal …